Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: An anthrax toxin receptor

被引:101
|
作者
Lacy, DB
Wigelsworth, DJ
Scobie, HM
Young, JAT
Collier, RJ
机构
[1] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA
[2] Salk Inst Biol Studies, Infect Dis Lab, La Jolla, CA 92037 USA
关键词
D O I
10.1073/pnas.0401506101
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Anthrax toxin is released from Bacillus anthracis as three monomeric proteins, which assemble into toxic complexes at the surface of receptor-bearing host cells. One of the proteins, protective antigen (PA), binds to receptors and orchestrates the delivery of the other two (the lethal and edema factors) into the cytosol. PA has been shown to bind to two cellular receptors: anthrax toxin receptor/tumor endothelial marker 8 and capillary morphogenesis protein 2 (CMG2). Both are type 1 membrane proteins that include an approximate to200-aa extracellular von Willebrand factor A (VWA) domain with a metal ion-dependent adhesion site (MIDAS) motif. The anthrax toxin receptor/tumor endothelial marker 8 and CMG2 VWA domains share approximate to60% amino acid identity and bind PA directly in a metal-dependent manner. Here, we report the crystal structure of the CMG2 VWA domain, with and without its intramolecular disulfide bond, to 1.5 and 1.8 Angstrom, respectively. Both structures contain a carboxylate ligand-mimetic bound at the MIDAS and appear as open conformations when compared with the VWA domains from alpha-integrins. The CMG2 structures provide a template to begin probing the high-affinity CMG2-PA interaction (200 pM) and may facilitate understanding of toxin assembly/internalization and the development of new anthrax treatments. The structural data also allow molecular interpretation of known CMG2 VWA domain mutations linked to the genetic disorders, juvenile hyaline fibromatosis, and infantile systemic hyalinosis.
引用
收藏
页码:6367 / 6372
页数:6
相关论文
共 50 条
  • [1] Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor
    Scobie, HM
    Rainey, GJA
    Bradley, KA
    Young, JAT
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (09) : 5170 - 5174
  • [2] Binding of the von Willebrand Factor A Domain of Capillary Morphogenesis Protein 2 to Anthrax Protective Antigen Vaccine Reduces Immunogenicity in Mice
    de Oliveira, Fabiana Freire Mendes
    Mamillapalli, Sireesha
    Gonti, Srinivas
    Brey, Robert N.
    Li, Han
    Schiffer, Jarad
    Casadevall, Arturo
    Bann, James G.
    MSPHERE, 2020, 5 (01):
  • [3] Molecular characterization of capillary morphogenesis protein-2: An anthrax toxin receptor
    Martin, GS
    Davis, GE
    MOLECULAR BIOLOGY OF THE CELL, 2004, 15 : 313A - 313A
  • [4] Crystal structure of the A3 domain of human von Willebrand factor
    Huizinga, EG
    vanderPlas, RM
    Sixma, JJ
    Kroon, J
    Gros, P
    THROMBOSIS AND HAEMOSTASIS, 1997, : S1530 - S1530
  • [5] Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo
    Liu, Shihui
    Crown, Devorah
    Miller-Randolph, Sharmina
    Moayeri, Mahtab
    Wang, Hailun
    Hu, Haijing
    Morley, Thomas
    Leppla, Stephen H.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (30) : 12424 - 12429
  • [6] A complex role of anthrax toxin receptor 2 polymorphisms and capillary morphogenesis protein 2 in ankylosing spondylitis pathogenesis
    Zhijian Zhang
    Kun Yu
    Dongfa Dai
    Fang Yuan
    Fei Liang
    Nan Liu
    Yongzhi Xi
    Yu-Ying Sun
    Clinical Rheumatology, 2016, 35 : 2243 - 2250
  • [7] A complex role of anthrax toxin receptor 2 polymorphisms and capillary morphogenesis protein 2 in ankylosing spondylitis pathogenesis
    Zhang, Zhijian
    Yu, Kun
    Dai, Dongfa
    Yuan, Fang
    Liang, Fei
    Liu, Nan
    Xi, Yongzhi
    Sun, Yu-Ying
    CLINICAL RHEUMATOLOGY, 2016, 35 (09) : 2243 - 2250
  • [8] Crystal structure of the von Willebrand factor A3 domain.
    Bienkowska, J
    Cruz, MA
    Handin, RI
    Liddington, RC
    CIRCULATION, 1996, 94 (08) : 1266 - 1266
  • [9] Crystal structure of the A3 domain of human von Willebrand factor: implications for collagen binding
    Huizinga, EG
    vanderPlas, RM
    Kroon, J
    Sixma, JJ
    Gros, P
    STRUCTURE, 1997, 5 (09) : 1147 - 1156
  • [10] A Novel Splice Site Mutation in Anthrax Toxin Receptor 2 (Capillary Morphogenesis Protein 2) Gene Results in Systemic Hyalinosis
    Priyadharshini, Indhra
    Varala, Sirisha
    Bharadwaj, Tallapaka Karthik
    Krishna, Ananthula Venkata
    INDIAN JOURNAL OF PAEDIATRIC DERMATOLOGY, 2022, 23 (03) : 242 - 244